A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF

Background. The development of new methods for delivering biologically active substances to the surgical site is a promising area of modern surgery. One of the biologically active substances used to stimulate regeneration is the vascular endothelial growth factor (VEGF). The search for ways to gradu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	I. S. Kurganskiy
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2021
Materias:	trachea medicinal film vegf experiment rat Science Q
Acceso en línea:	https://doaj.org/article/ddd6fd459cd44acba425b6f8c3ba4e7d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ddd6fd459cd44acba425b6f8c3ba4e7d
record_format	dspace
spelling	oai:doaj.org-article:ddd6fd459cd44acba425b6f8c3ba4e7d2021-11-23T06:14:45ZA Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF2541-94202587-959610.29413/ABS.2020-5.6.38https://doaj.org/article/ddd6fd459cd44acba425b6f8c3ba4e7d2021-01-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/2530https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596Background. The development of new methods for delivering biologically active substances to the surgical site is a promising area of modern surgery. One of the biologically active substances used to stimulate regeneration is the vascular endothelial growth factor (VEGF). The search for ways to gradually and over a long period of time deliver VEGF to the surgical site is a promising area of research.Aim. To develop a method for delivering VEGF to the surgical site and to assess its elimination in the early postoperative period.Materials and methods. The study included 78 male Wistar rats at the age of 10 months. All animals underwent reconstructive surgery on the trachea, the animals were divided into 3 groups: group 1 – without a medicinal film, group 2 – with a medicinal film of prolonged action, group 3 – with a medicinal film of prolonged action containing VEGF. Blood sampling was carried out on days 1, 3, and 21 of the study, using the method of enzyme-linked immunosorbent assay to determine the level of VEGF in blood plasma, the unit of measurement was pg/ml.Results. A long-acting medicinal film containing VEGF has been developed. It was revealed that the use of a medicinal film containing VEGF significantly increases the VEGF index in blood plasma by 26 times starting from the first day of the study and remained high throughout the study.Conclusion. The results obtained indicate the effectiveness of the developed medicinal film of prolonged action. Elimination of VEGF starts from the first day of the study and lasts up to 21 days. High VEGF indices, according to the authors, are associated with the exogenous introduction of VEGF into the animal organism in the form of a prolonged-action film and the induction of endogenous VEGF in rats.I. S. KurganskiyScientific Сentre for Family Health and Human Reproduction Problemsarticletracheamedicinal filmvegfexperimentratScienceQRUActa Biomedica Scientifica, Vol 5, Iss 6, Pp 282-285 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	trachea medicinal film vegf experiment rat Science Q
spellingShingle	trachea medicinal film vegf experiment rat Science Q I. S. Kurganskiy A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
description	Background. The development of new methods for delivering biologically active substances to the surgical site is a promising area of modern surgery. One of the biologically active substances used to stimulate regeneration is the vascular endothelial growth factor (VEGF). The search for ways to gradually and over a long period of time deliver VEGF to the surgical site is a promising area of research.Aim. To develop a method for delivering VEGF to the surgical site and to assess its elimination in the early postoperative period.Materials and methods. The study included 78 male Wistar rats at the age of 10 months. All animals underwent reconstructive surgery on the trachea, the animals were divided into 3 groups: group 1 – without a medicinal film, group 2 – with a medicinal film of prolonged action, group 3 – with a medicinal film of prolonged action containing VEGF. Blood sampling was carried out on days 1, 3, and 21 of the study, using the method of enzyme-linked immunosorbent assay to determine the level of VEGF in blood plasma, the unit of measurement was pg/ml.Results. A long-acting medicinal film containing VEGF has been developed. It was revealed that the use of a medicinal film containing VEGF significantly increases the VEGF index in blood plasma by 26 times starting from the first day of the study and remained high throughout the study.Conclusion. The results obtained indicate the effectiveness of the developed medicinal film of prolonged action. Elimination of VEGF starts from the first day of the study and lasts up to 21 days. High VEGF indices, according to the authors, are associated with the exogenous introduction of VEGF into the animal organism in the form of a prolonged-action film and the induction of endogenous VEGF in rats.
format	article
author	I. S. Kurganskiy
author_facet	I. S. Kurganskiy
author_sort	I. S. Kurganskiy
title	A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_short	A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_full	A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_fullStr	A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_full_unstemmed	A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_sort	method of manufacturing a long-acting medicinal film containing vegf
publisher	Scientific Сentre for Family Health and Human Reproduction Problems
publishDate	2021
url	https://doaj.org/article/ddd6fd459cd44acba425b6f8c3ba4e7d
work_keys_str_mv	AT iskurganskiy amethodofmanufacturingalongactingmedicinalfilmcontainingvegf AT iskurganskiy methodofmanufacturingalongactingmedicinalfilmcontainingvegf
_version_	1718416915427229696

A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF

Ejemplares similares